Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer-Reference-Cited by-同舟云学术

Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

Published:2020-08-12 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Raimondi Alessandra,Sepe Pierangela,Zattarin Emma,Mennitto Alessia,Stellato Marco,Claps Melanie,Guadalupi Valentina,Verzoni Elena,de Braud Filippo,Procopio Giuseppe

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference74 articles.

1. Renal cancer.;Capitanio;Lancet.,2016

2. External validation and comparison with other models of the international metastatic renal-cell carcinoma database consortium prognostic model: a population-based study.;Heng;Lancet Oncol.,2013

3. Exposure to multiple lines of treatment and survival of patients with metastatic renal cell carcinoma: a real-world analysis.;Ratta;Clin Genitourin Cancer.,2018

4. A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer.;Albiges;Eur Urol.,2015

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy Applications for Thymine Dimers and WT1 Antigen in Renal Cancers: A Comparative Statistical Analysis;Journal of Personalized Medicine;2024-05-23

2. Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma;Scientific Reports;2024-04-13

3. Label-Free SERS of Urine Components: A Powerful Tool for Discriminating Renal Cell Carcinoma through Multivariate Analysis and Machine Learning Techniques;International Journal of Molecular Sciences;2024-03-31

4. Impact of Tumor Grade Distribution on Genetic Alterations in Clear Cell Renal Cell Carcinoma and Prostate Cancer;Cancer Genomics - Proteomics;2024-02-29

5. Clinical Importance of Cannabinoid Type 1 Receptor (CB1R) and Cannabinoid Type 2 Receptor (CB2R) Expression in Renal Cell Carcinoma;Cureus;2024-02-28